FDA Oks 1st muscular dystrophy drug; awaits proof it works

WASHINGTON (AP) — Federal regulators on Monday granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication. The approval comes nearly five months after the Food and Drug Administration and a panel of outside advisers panned the drug, saying […]